Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Laboratorios Farmaceuticos ROVI
ROVICurrent price
62.15 EUR
-3.05 EUR (-4.68%)
Last closed
65.2 EUR
Company
www.rovi.es
ISIN
ES0157261019
Sector
Healthcare
Industry
Biotechnology
Exchange
Madrid Exchange
Capitalization
3 179 159 040 EUR
Yield for 12 month
+20.21 %
1Y
3Y
5Y
10Y
15Y
ROVI
Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas. Its principal products include Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitamine D3 Rovi, Exxiv, Prinvil, Rhodogil, Glufan, Hibor, Hirobriz Breezhaler, Neparvis, Medicebran, Medikinet, Mysimba, Orvatez, Tryptizol, Ulunar Breezhaler, and Volutsa; and hospital products, such as Iomeron and Iopamiro, Multihance and Y Prohance, Sonovue, Empowercta+, Empowermr, and CT Express, Fibrilin, and Sodium Heparin Rovi. It also provides contract-manufacturing services to other companies for a range of pharmaceutical forms, including prefilled syringes, vials, suppositories, tablets, and sachets. Laboratorios Farmaceuticos Rovi, S.A. was incorporated in 1946 and is headquartered in Madrid, Spain. Laboratorios Farmaceúticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L. Address: Calle JosE Isbert, 2, Madrid, Spain, 28223
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
90.81 EURP/E ratio
19.544Dividend Yield
1.83 %Current Year
+829 509 000 EUR
Last Year
+817 698 000 EUR
Current Quarter
+178 161 000 EUR
Last Quarter
+151 175 000 EUR
Current Year
+492 285 000 EUR
Last Year
+519 613 000 EUR
Current Quarter
+110 315 000 EUR
Last Quarter
+85 670 000 EUR
Key Figures ROVI
1 year
3 years
5 years
10 years
EBITDA
233 886 000 EUR
Operating Margin TTM
PE Ratio
19.544
Return On Assets TTM
15.55 %
PEG Ratio
–
Return On Equity TTM
29.65 %
Wall Street Target Price
90.81 EUR
Revenue TTM
799 248 000 EUR
Book Value
10.28 EUR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
9.9 %
Dividend Yield
1.83 %
Gross Profit TTM
512 429 000 EUR
Earnings per share
3.18 EUR
Diluted Eps TTM
3.18 EUR
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
53.1 %
Profit Margin
20.64 %
Dividend Analytics ROVI
Dividend growth over 5 years
972 %Continuous growth
4 yearsPayout Ratio 5 years average
16 %Dividend History ROVI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
1.1
Ex Dividend Date
08.07.2024
Forward Annual Dividend Yield
1.78 %
Last Split Factor
–
Payout Ratio
37.91 %
Last Split Date
–
Dividend Date
–
Stock Valuation ROVI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
19.544
Forward PE
36.63
Enterprise Value Revenue
4.0735
Price Sales TTM
3.9777
Enterprise Value EBITDA
13.5369
Price Book MRQ
6.6776
Financials ROVI
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ROVI
For 52 weeks
51.06 EUR
93.81 EUR
50 Day MA
73.85 EUR
Shares Short Prior Month
–
200 Day MA
79.33 EUR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart